Telmisartan 40mg Tablet

Adult dose

For essential hypertension, the recommended dosage is once daily 40 mg of Telmisartan taken orally with water, regardless of meals. A dose of once daily 20 mg may also be effective depending on the patient. If necessary, the dosage can be increased to 80 mg once daily, and the maximum antihypertensive effect is observed 4 to 8 weeks after increasing the dosage. For reduction of cardiovascular disease risk, it is recommended to take 80 mg once daily of this medication orally with water.

This medication can cause serious harm or death to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Those with hypersensitivity to this medication or its components, pregnant or potentially pregnant women, nursing mothers, individuals with severe liver impairment, hereditary angioedema patients, and patients with diabetes or moderate to severe kidney impairment should not take this medication. Elderly patients, those with hyperkalemia, patients with mild to moderate liver impairment, patients with heart valve disease or ischemic heart disease, those with gastrointestinal diseases, patients with renovascular hypertension, and those with severe kidney impairment should take this medication cautiously, with dose adjustments and monitoring of conditions as necessary. While taking this medication, blood pressure, kidney function, and electrolyte levels should be checked regularly, and especially due to the risks of hyperkalemia and renal function impairment, if any unusual symptoms appear, consult medical professionals immediately. This medication lowers blood pressure, which can lead to symptoms such as hypotension, syncope, and dizziness. If these symptoms occur, lie down and rest immediately and visit a hospital if needed. Also, angioedema may occur, so if swelling occurs in the face, lips, tongue, or you experience difficulty breathing, discontinue use immediately and seek emergency treatment. This medication may have interactions when used in combination with other antihypertensive drugs, so be sure to inform your healthcare provider of any medications you are taking. It is advisable to stop taking this medication at least 24 hours before surgery, and caution is required while driving or operating machinery due to the risk of dizziness or fainting. This medication contains sorbitol, thus those with hereditary fructose intolerance should avoid it, and its safety and efficacy in children and adolescents under 18 years have not been established, so it is not recommended. In case of overdose, symptoms such as hypotension, tachycardia, dizziness, and renal failure may appear, and immediate medical treatment should be sought. This medication should be kept out of the reach of children and transferring it to other containers is not advisable for maintaining quality and safety.

Serious side effects

Hives, severe swelling, angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin adverse reactions, asthma attack, respiratory issues with cough and fever, difficulty breathing or shortness of breath, liver issues (jaundice), yellowing of skin or eyes, profound lethargy, sudden and severe headache

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should remain at room temperature between 1°C and 30°C. This will help maintain the medication's efficacy and safety for a long time.

Appearance

White or almost white, biconvex, round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle